Overview
Portfolio
More
Abony Capital
New York, United States
Abony Capital focuses on seed‑stage vertical AI startups, targeting post‑product, post‑revenue companies that apply artificial intelligence to specific industry verticals. They provide capital and strategic support to he...
Portfolio
5+
Employees
30+
Founded
1997
AUM
N/A
Investment focus
Stages
Seed
Industries
Artificial Intelligence
Geographic scope
United States
Sources
Abony Capital
Abony Capital focuses on seed‑stage vertical AI startups, targeting post‑product, post‑revenue companies that apply artificial intelligence to specific industry verticals. They provide capital and strategic support to help AI‑driven founders scale their solutions and achieve market traction.
Portfolio
5+
Employees
30+
Founded
1997
AUM
N/A
Stages
Seed
Industries
Artificial Intelligence
Geographic scope
United States
Sources
Showing 5 of 5 matched portfolio companies
Einride develops digital, electric, and autonomous shipping solutions that enhance the efficiency and sustainability of freight transportation. By integrating advanced connectivity and smart charging technologies, the company addresses the need for cleaner and safer logistics in the heavy-duty transport sector.
Funding: $652.3M
Rough estimate of the amount of funding raised
Funding: $652.3M
Rough estimate of the amount of funding raised
Science is a clinical-stage technology company developing biohybrid neural interfaces and advanced neural recording electronics to address serious unmet medical needs in neuroscience. Their technologies aim to enhance neural communication and restore vision, facilitating new treatment possibilities for patients with neurological disorders.
Funding: $186.0M
Rough estimate of the amount of funding raised
Funding: $186.0M
Rough estimate of the amount of funding raised
Cellular Intelligence is developing the first universal virtual cell-signaling model to understand and manipulate biological processes. This platform aims to shift biology from a deterministic state to one of designable outcomes. The company provides computational tools for advanced biological research and therapeutic development.
Funding: $10.3M
Rough estimate of the amount of funding raised
Funding: $10.3M
Rough estimate of the amount of funding raised
VitroLabs utilizes stem cell-based technologies to cultivate real leather, allowing for the production of high-quality materials without the need for animal slaughter. This approach addresses the environmental and ethical concerns associated with traditional leather manufacturing by providing a sustainable alternative that maintains the authentic characteristics of leather.
Funding: $50.5M
Rough estimate of the amount of funding raised
Funding: $50.5M
Rough estimate of the amount of funding raised
Provides a cloud-based AI voice conversation platform that automates inbound and outbound call operations using natural language processing and machine learning. It reduces operational costs, increases call volume, and improves lead conversion rates by enabling businesses to handle 24/7 customer interactions with up to 80% connect rates and instant response times.
Funding: $5.1M
Rough estimate of the amount of funding raised
Funding: $5.1M
Rough estimate of the amount of funding raised